AC Immune Initiates Phase 1 Clinical Trial of NLRP3 Inhibitor ACI-19764 is an orally available highly brain-penetrant small molecule NLRP3 inhibitorNLRP3 inhibitors are a major new class of compounds ...

Today’s data centers have developed a ravenous appetite for power as they tackle large language models and other ...

Compact 3 kW programmable AC-DC power supplies gain a new wide-range three-phase input variant that widens voltage ...

A phase 3 clinical trial, led by Professor Chloe Orkin of Queen Mary University of London, has shown that a new, daily oral ...

In all, 63 people have been charged in the sweeping investigation — from slammers and spotters to attorneys accused of ...

Monaco, Porto, Roma, Villarreal, Ajax and Bodø/Glimt are among those to feature as we recall the Champions League's biggest ...

MEC 26-XD+ MEC Aerial Work Platforms Also at CONEXPO-CON/AGG, MEC will feature its recently introduced PLUS (+) slab electric ...

At ELMIASOLAR 2026, Swatten showcased its complete portfolio of energy storage solutions, whose capabilities naturally align with Sweden’s rapidly evolving energy landscape. The lineup featured the ...

Bodo/Glimt knock out last year's finalists Inter Milan in one of the biggest upsets in Champions League history and now the ...

A USMNT trio can claim UEFA Champions League glory before the 2026 FIFA World Cup, but only two are getting playing time.

ZYNRELEF® and APONVIE® Drive 65% Year-Over-Year Net Revenue Growth in Acute Care Franchise– Achieved $154.9 Million in 2025 Net Revenue– Issues ...

Ideal Power Inc. ( IPWR) Discusses Leadership Changes, Capital Raise and Commercialization Strategy Update February 26, 2026 1:00 PM EST Jeff Christensen Casey Ryan - WestPark Capital, Inc., Research ...